Facebook
Twitter
Telegram
Report an ErrorJaguar Health Balance Sheet 2011-2024 | JAGX
Annual Balance Sheet Jaguar Health
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-5.24 M | -4.26 M | -15.9 M | -4.3 M | 3.73 M | 13.5 M | 15.9 M | 2.94 M | -1.74 M | -1.37 M | 334 K | - | - |
Long Term Debt |
886 K | 725 K | 919 K | - | 450 K | - | 11 M | 1.82 M | 4.1 M | - | - | - | - |
Long Term Debt Current |
348 K | 483 K | 240 K | - | 337 K | - | 1.61 M | 1.92 M | 1.71 M | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 10.3 M | 9 M | 11 M | 1.82 M | 4.1 M | 1.88 M | - | - | - |
Total Current Liabilities |
14 M | 30.3 M | 15.5 M | 13.2 M | 15.4 M | 26.7 M | 15.4 M | 4.19 M | 3.91 M | - | - | - | - |
Total Liabilities |
45.9 M | 48.8 M | 41.4 M | 25.6 M | 25.7 M | 35.7 M | 26.4 M | 6.02 M | 8.01 M | 4.66 M | 724 K | - | - |
Deferred Revenue |
- | - | - | - | - | - | 177 K | 224 K | 252 K | 23.8 K | - | - | - |
Retained Earnings |
-308 M | -267 M | -219 M | - | -133 M | -94.6 M | -62.4 M | -40.4 M | -25.7 M | -11.1 M | -801 K | - | - |
Total Assets |
50.8 M | 47.5 M | 53.3 M | 42.8 M | 36.4 M | 41 M | 43.6 M | 3.56 M | 12.4 M | 5.76 M | 289 K | - | - |
Cash and Cash Equivalents |
6.47 M | 5.47 M | 17.1 M | 8.09 M | 3.5 M | 2.57 M | 521 K | 951 K | 7.7 M | 845 K | - | - | - |
Book Value |
4.9 M | -1.36 M | 11.9 M | 17.2 M | 10.7 M | 5.38 M | 17.3 M | -2.45 M | 4.4 M | 1.1 M | -435 K | - | - |
Total Shareholders Equity |
4.9 M | -1.36 M | 11.9 M | 17.2 M | 10.7 M | 5.38 M | 17.3 M | -2.45 M | 4.4 M | -8.24 M | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Jaguar Health
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
873 K | 351 K | 495 K | 627 K | 725 K | 738 K | 868 K | 921 K | 919 K | 826 K | 907 K | - | - | - | - | - | - | - | 116 K | 116 K | - | - | 10.8 M | 10.9 M | 11 M | - | 836 K | 11 M | 1.82 M | 1.82 M | 1.82 M | 1.82 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
41.1 M | 44 M | 46.3 M | 49.3 M | 48.8 M | 47.7 M | 47.1 M | 44.8 M | 41.4 M | 37.7 M | 37.8 M | 36.8 M | 25.6 M | 25.6 M | 25.6 M | 25.6 M | 15.8 M | 15.8 M | 15.8 M | 15.8 M | 26.7 M | 26.7 M | 26.7 M | 26.7 M | 26.4 M | 26.4 M | 26.4 M | 26.4 M | 6.02 M | 6.02 M | 6.02 M | 6.02 M | 8.01 M | 8.01 M | 8.01 M | 8.01 M | 5.35 M | 5.44 M | 5.44 M | 5.44 M | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
170 K | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.5 M | - | - | - | - | - | - | - | - | - | 177 K | 224 K | 185 K | 208 K | 224 K | 224 K | 224 K | 224 K | 252 K | 252 K | 252 K | 252 K | 23.8 K | 23.8 K | 23.8 K | 23.8 K | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-317 M | -299 M | -291 M | -279 M | -267 M | -259 M | -247 M | -237 M | -219 M | -205 M | -193 M | -179 M | -167 M | -167 M | -167 M | -167 M | -133 M | -133 M | -133 M | -133 M | -94.6 M | -94.6 M | -94.6 M | -94.6 M | -62.4 M | -62.4 M | -62.4 M | -62.4 M | -40.4 M | -40.4 M | -40.4 M | -40.4 M | -25.7 M | -25.7 M | -25.7 M | -25.7 M | -9.41 M | -9.41 M | -9.41 M | -9.41 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
55.4 M | 45.4 M | 52.2 M | 56.9 M | 47.5 M | 51.3 M | 49.9 M | 52.9 M | 53.3 M | 59.3 M | 69.5 M | 68.7 M | 42.8 M | 42.8 M | 42.8 M | 42.8 M | 36.4 M | 36.4 M | 36.4 M | 36.4 M | 41 M | 41 M | 41 M | 41 M | 43.6 M | 43.6 M | 43.6 M | 43.6 M | 3.56 M | 3.56 M | 3.56 M | 3.56 M | 12.4 M | 12.4 M | 12.4 M | 12.4 M | 4.42 M | 4.51 M | 4.51 M | 4.51 M | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
11.7 M | 3.23 M | 8.63 M | 14.4 M | 5.47 M | 10.6 M | 9.01 M | 17.5 M | 17.1 M | 12.4 M | 31.9 M | 32.2 M | 8.09 M | 1.35 M | 8.09 M | 8.09 M | 3.5 M | 3.5 M | 3.5 M | 3.5 M | 2.57 M | 2.57 M | 2.57 M | 2.57 M | 521 K | 521 K | 521 K | 521 K | 951 K | 951 K | 951 K | 951 K | 7.7 M | 7.7 M | 7.7 M | 7.7 M | 845 K | 845 K | 845 K | 845 K | 185 K | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
14.3 M | 1.42 M | 5.83 M | 7.66 M | -1.36 M | 3.6 M | 2.76 M | 8.11 M | 11.9 M | 21.6 M | 31.8 M | 31.9 M | 17.2 M | 17.2 M | 17.2 M | 17.2 M | 20.6 M | 20.6 M | 20.6 M | 20.6 M | 14.4 M | 14.4 M | 14.4 M | 14.4 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M | -2.45 M | -2.45 M | -2.45 M | -2.45 M | 4.4 M | 4.4 M | 4.4 M | 4.4 M | -930 K | -930 K | -930 K | -930 K | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
11.8 M | 1.42 M | 5.83 M | 7.66 M | -1.36 M | 3.6 M | 2.76 M | 8.11 M | 11.9 M | 21.6 M | 31.8 M | 31.9 M | 17.2 M | 7.81 M | 17.2 M | 17.2 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 5.38 M | 5.38 M | 5.38 M | 5.38 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M | -2.45 M | -2.45 M | -2.45 M | -2.45 M | 4.4 M | 4.4 M | 4.4 M | 4.4 M | -8.24 M | -8.24 M | -8.24 M | -8.24 M | -435 K | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency